{"name":"T-ACE Medical Co., Ltd","slug":"t-ace-medical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxONUcyZkZtLVFSSWFpdGhncGlEYXF3OVZNV0lrMzB0M1dKNlhQUHFuLXZfT1V4NGdMSnV0UC1VektMVFA0SV8wQmd1LWxFTDZlZ2FlWlVHY3hYdjlEbEtIM3ctX2NqbHdkaTBpYnUwODdVTjNPR0xjeTFjTnZZejhVMHVnQ3JRcEoyS3lOSUtlcFBhRGc?oc=5","date":"2025-11-06","type":"pipeline","source":"Insightace Analytic","summary":"Immuno-Oncology Cell Therapy Market Share, Size, Growth and Forecast to 2034 - Insightace Analytic","headline":"Immuno-Oncology Cell Therapy Market Share, Size, Growth and Forecast to 2034","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-31","type":"trial","source":"Medical Dialogues","summary":"Merck, Eisai to shut down late stage trial of liver cancer therapy - Medical Dialogues","headline":"Merck, Eisai to shut down late stage trial of liver cancer therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOSGJVZWpSZmRITW9qWTBIVXRlMklQREg4QloycUhCdG82SExndXIzU2twRUlDejVmc3Y5R1hKTkNudlBScHZiSE1BSGRBVjY4S2lId3hmUE5rc2JEU2pfZnZpNFdkMEJjMlBhLVFEek1kQ1pCR1FVM2ZOT1ZNT1dXN3BCYWVyUQ?oc=5","date":"2025-07-24","type":"trial","source":"Insightace Analytic","summary":"Transdermal Medical Patch Market Key Players Business Strategies Study - Insightace Analytic","headline":"Transdermal Medical Patch Market Key Players Business Strategies Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPbVIwRzc4eW4yZDVldmVGZ1pDY3ZfTGFUal92TU9sQnl4NHJiaXlZdHdUNGZ6LVE0RGhjbUlJaWRRcExfaEdSVmFlYnVyd1g3M1hTb0o3VkF4Wm5CVTlhT0RZZGJoZ2Ryb3EyNDZZczlDTDAxeC1tSWZBUVNsRTk2UQ?oc=5","date":"2025-01-31","type":"pipeline","source":"MarketsandMarkets","summary":"Interventional Oncology Market worth $4.24 billion by 2029 - MarketsandMarkets","headline":"Interventional Oncology Market worth $4.24 billion by 2029","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQaDR4cDU3RmtOVzJCcl96YmRQUUYyU1Q5R0plN1kySWFUS0lHLU5fbnp5bEIwalZ1QVpTUnRyaERsQVFSc3hXS0hfLXZzUl9jUk5Wem1QNEdfSmNyNHhWTWFrcEprVzAxMzNMbjNlMXVKVUduYk1lY2gwTzU0MG1NLW1pTTV3U3NmMTJHb1VBQzJudTQ?oc=5","date":"2024-09-18","type":"pipeline","source":"Grand View Research","summary":"China Liver Cancer Drug Market Size | Industry Report, 2030 - Grand View Research","headline":"China Liver Cancer Drug Market Size | Industry Report, 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPTWwtS05JU1NPLTlTRkZTNU9zMHJhUEc2U1J2Y1JyclJHYlBsNEdVQi0wUkZhbGY3eFBPZjUyakNndXpqSERLVHU2c3Y1Wi1LMUpFNk50TG5BOGVXYzhpVXBTa1A2eDktWURIaFoxb1NGWDBud3hKTmlxcDFmd0otWUFiVXVSTjNrcW05Y2ZiWUM?oc=5","date":"2024-02-20","type":"pipeline","source":"GOV.UK","summary":"Over 500 companies named for not paying minimum wage - GOV.UK","headline":"Over 500 companies named for not paying minimum wage","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxNT2FfZUNRYzhyM0NwWDdoNk4wbnd6VHIzbE01Q0JKNEZUUzBrNVFOSXdiNy1KRGg3R0VDMmxMTlJMRlpRVGNyM1lqdm8xTjE4Zl9mRm1XZDlucDhVejRkNzZwOE9VSUgzSTgwbXNYZUJNQ1VsOXZaZUxoMkRTTWF5VjFKX0ZuaTdIQTc5THF1TVZjTXZXbUVhYWROZS02YWZzTWx3RTZXN0RKdTd4Q3JZdWlVVkdNS1VrWGcydDktM29JQTFLYzRKYnRkcVpFQ2VMRU5vZC1wQWxOcGIxX2E3RVBBY1dLOFBnOHYzbXRCSU1nc2h0NEk0MUxMMA?oc=5","date":"2024-01-19","type":"pipeline","source":"AstraZeneca","summary":"Imfinzi plus transarterial chemoembolisation (TACE) and bevacizumab reduced the risk of disease progression or death by 23% vs. TACE in liver cancer eligible for embolisation - AstraZeneca","headline":"Imfinzi plus transarterial chemoembolisation (TACE) and bevacizumab reduced the risk of disease progression or death by ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9yV1RtOEtwQzA5a1VJM3ZVWC1BYm9ILUhoYmNGWWZ5VkYwdWhjOXNfbV8tNDl6c09jLVBqX0pxU3Qxek1LdUUwekJKS2o3MmlqdTBNVnFmRkQ2dll5eFk4?oc=5","date":"2020-03-10","type":"pipeline","source":"nature.com","summary":"Transarterial chemoembolization with medium-sized doxorubicin-eluting Callisphere is safe and effective for patients with hepatocellular carcinoma - nature.com","headline":"Transarterial chemoembolization with medium-sized doxorubicin-eluting Callisphere is safe and effective for patients wit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOMFhuS2N1Y2hBWUxVSnRGUDZDeGJaWnN2RWY0WHhIMW5DTnphRWltdWdsYmZHbksxLTNwNFcyQkJrd0J2OWVQdFJkel8wd0ZWSjFUcFNFYktQQWlsYnZ0djdOQjBTSUZGWHVENWNwQUdWMGd3SVRtSlZYZGczMWlHam1XbkpmSWVMcnlIdw?oc=5","date":"2019-08-02","type":"pipeline","source":"MarketsandMarkets","summary":"Embolotherapy Market Growth Drivers & Opportunities - MarketsandMarkets","headline":"Embolotherapy Market Growth Drivers & Opportunities","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}